Continue to build distribution momentum for their exclusive Amanita Muscaria AME-1 extract
Toronto, Ontario–(Newsfile Corp. – June 14, 2022) – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” Where “psychedelic“), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is delighted to announce that it will be launching its online store today.
The Company has worked tirelessly over the past few months to develop this new distribution channel for its products. The new online store will start by selling branded products such as t-shirts, hats, hoodies and other accessories. The Company is currently testing its e-commerce purchase funnel before launching its snippet calm, the first Amanita Muscaria mushroom extract approved for sale in the United States.
Chief Commercial Officer Matthew Singh said, “A detailed e-commerce strategy is an integral part of any modern CPG entity. Ours is designed to evolve not only our product, but also our brand and awareness of the Amanita Muscaria mushroom. Purchasing direct from Psyched Wellness will yield multiple user benefits, and this is only the first phase of our eComm approach, which will also include third-party sellers. We chose to start with our merchandise to ensure the consumer experience is perfected before launching the pre-sale of our tincture, Calm. Our line of mushroom-derived products with AME-1 are approved for sale anywhere in the United States, no prescription needed. We are delighted to bring a legal Amanita Muscaria product to the general public for the first time. Many thanks to Del, our marketing team and the developers of Spark for a job well done!”
Visit www.psyched-wellness.com for more information on how to order.
For more information, please contact:
Chief executive officer
Psyched Wellness Ltd.
Neither the Canadian Securities Exchange nor its regulation services provider has reviewed or accepts responsibility for the adequacy or accuracy of this release.
About Psyched Wellness Ltd. :
Psyched Wellness Ltd. is a Canadian health supplement company dedicated to the distribution of mushroom-derived products and related consumer packaged goods. The company’s goal is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category. The company is developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help achieve three health goals: to promote stress relief, relaxation and to aid in restorative sleep.
Caution Regarding Forward-Looking Information
This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. These statements relate to future events or future performance. Use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “plan”, “estimate” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current beliefs or assumptions as to the outcome and timing of such future events. Forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the Company’s ability to develop products derived from Amanita Muscaria; the safety of consumption of Amanita Muscaria and the safety and purity of all of its extracts; and (ii) the potential uses and benefits of Amanita Muscaria.
The forward-looking information contained in this press release is based on certain assumptions and expected future events, namely: the Company’s ability to continue as a going concern; the Company’s ability to pursue the development of its mushroom-derived products and related consumer packaged goods; the continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; and the continued growth of the Company.
These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including, but not limit thereto: the potential inability of the Company to continue as an ongoing operation; the risks associated with possible governmental and/or regulatory measures concerning the activities of the Company; competition in the psychedelic market; risks regarding the safety of consumption of Amanita Muscaria and the safety and purity of any extracts thereof; and the risk that there is no potential benefit from consuming Amanita Muscaria.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. Such information, although considered reasonable by management when prepared, may prove to be incorrect and actual results may differ materially from those anticipated.
The forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise, or to explain any material differences between subsequent actual events and such forward-looking information, except as required by applicable law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/127578